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BACKGROUND: Although the aetiology of prostate cancer remains unknown, we hypothesised that chronic bacterial insult has a major
role in prostate carcinogenesis.
METHODS: Male C3H/HeOuJ mice, infected with phosphate-buffered saline or Escherichia coli bacteria, were killed at 5 days, or at
12 or 26 weeks. Harvested prostate tissues were evaluated for inflammatory responses and immunostained for neoplastic
transformation markers.
RESULTS: All infected mice developed bacterial prostatitis. Control mice had no prostate infections or inflammation. Mice infected for
5 days showed foci of acute inflammation with infiltrating neutrophils and epithelial necrotic debris in the prostatic glandular lumen. All
mice infected for 12 weeks had evidence of chronic inflammation with dense inflammatory infiltrates in the stroma. The prostatic
epithelium showed varying degrees of atypical hyperplasia with increased epithelial cell layers and cytological atypia. At 26 weeks, the
dysplastic changes were more pronounced and mimicked a prostatic intraepithelial neoplasia and high-grade dysplasia. Prostatic
glands exhibiting reactive dysplasia had a stronger staining for oxidative DNA damage, increased epithelial cell proliferation, and a
decrease in androgen receptor, GSTP1, p27
Kip1, and PTEN expression, when compared with control prostate glands.
CONCLUSION: These data demonstrate that chronic inflammation induces focal prostatic glandular atypia and suggest a potential
linkage between inflammation and prostatic neoplasia.
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In spite of progress in diagnosis and treatment, prostate cancer
(CaP) remains a major public health problem in the male
population and the second leading cause of death among men in
the United States and in many Western industrialised countries.
Prostate cancer is predominantly a disease in men over 40 years of
age, and its incidence increases steeply in the seventh decade of
life. In 2008, an estimated 186360 men were diagnosed with CaP,
and it was estimated that 28660 deaths because of CaP occured
(Jemal et al, 2008). Widespread screenings for prostate-specific
antigen, digital rectal examination, and needle biopsy, as well as
standard treatment already in clinical use, have enhanced patient’s
survival by improving the detection of early and localised disease
(Hankey et al, 1999; Bartsch et al, 2008). In addition, it is likely
that better preventive measures will reduce the incidence of CaP
(Djavan et al, 2004). In contrast, there is still no effective cure for
those patients having extra-prostatic invasion, distant metastasis,
or hormone refractory CaP.
Although the exact aetiology of CaP is largely unknown, this
seems to be a multifactorial disease in which several environmental
and genetic factors are likely to be involved (Lichtenstein et al,
2000; Migliore and Coppede, 2002). Epidemiological studies have
shown that the incidence of CaP shows age, race, diet, and
geographical dependence (Lichtenstein et al, 2000; Nelson et al,
2002), with North Americans and Western Europeans showing
high rates of disease, whereas men in Asian nations experience
lower rates (Hsing et al, 2000). In addition to disparities in rates
between different populations and ethnic groups, three susceptible
genes, ribonuclease L (RNaseL) (Rokman et al, 2002), macrophage
scavenger receptor 1 (MSR1)( X uet al, 2002), and toll-like
receptor-4 (TLR-4) (Sun et al, 2007), have been associated with
familial CaP and all functions in host immune responses or in host
protection against cellular and genomic damage mediated by the
infection itself or by the inflammatory oxidants secreted by
leukocyte-infiltrating cells in response to infection. Other aetiolo-
gical factors such as high androgen levels (Feldman and Feldman,
2001), growth factor overexpression (Pollak, 2008), dietary
carcinogens (Cohen et al, 2000; Freeman et al, 2000; Kolonel
et al, 2000; Kooiman et al, 2000; Chan and Giovannucci, 2001;
Kolonel, 2001; Shapiro et al, 2001), sexually transmitted diseases
(Strickler and Goedert, 2001; Sutcliffe and Platz, 2008), and other
infectious agents (Dennis et al, 2002) may be associated with
increased CaP risk. Moreover, somatic targets of genomic damage
and inherited polymorphic variants of genes mediating androgen
action may enhance the progression of CaP (Nelson et al, 2003).
In the last decade, advanced cancer research has pointed out
several cancer-causing factors, including spontaneous replication
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serrors in DNA, endogenous and exogenous carcinogenic sub-
stances, irradiation such as ultraviolet and transduction of viral
oncogenes, and infection/inflammation. The role of infection/
inflammation in the initiation and progression of cancer has
been an area of intense scientific interest and usually considered
from the perspective that persistent inflammation in the context
of chronic infection or tissue injury might promote cell
transformation through DNA damage or that tumour cells
produce proinflammatory factors that derive chronic inflamma-
tion and tumour growth. It is estimated that 20–25% of all human
cancers are caused by chronic infection and inflammation
(De Marzo et al, 2007).
In the set of CaP, chronic prostatic inflammation is increasingly
often discussed as a critical component of tumour carcinogenesis
by generating a pathologically conducive microenvironment that
may favour the initiation and progression of cancer. A sustained
inflammatory microenvironment provides a constant supply of
various reactive nitrogen and oxygen species, reactive aldehydes,
cytokines, chemokines, and growth factors, which can alter crucial
biological processes responsible for maintaining normal cellular
homeostasis, leading to genomic instability and risk of CaP
development (Balkwill and Mantovani, 2001; Coussens and Werb,
2002; Gupta and Dubois, 2002; Philip et al, 2004; Hussain and
Harris, 2007). Moreover, proliferative inflammatory atrophy (PIA),
areas of epithelial proliferation associated with chronic inflamma-
tion, has been found to be closely associated with areas of prostatic
intraepithelial neoplasia (PIN) and CaP (De Marzo et al, 1999b).
Multiple epidemiological and clinical studies have identified an
association between specific bacterial infections and CaP (Dennis
et al, 2002). Nevertheless, a recent meta-analysis found a small
increased risk in the relative risk of CaP in men with a previous
medical history of clinical or symptomatic prostatitis (Dennis and
Dawson, 2002). Other investigations of infectious agents in the
aetiology of chronic prostatitis/chronic pelvic pain syndrome have
shown a correlation between inflammation and bacterial genes
detected in prostate biopsy specimens, indicating that localised
prostatic inflammation induced by chronic bacterial colonisation
may be attributed to CaP and could have an important role in
aetiology (Hochreiter et al, 2002). We postulated that chronic
bacterial insult is an important source of prostatic inflammation
and has a role in pre-neoplastic events. This hypothesis was tested
in a mouse model of chronic bacterial prostatitis, in which
biomarkers and histopathological changes associated with cellular
oxidative stress and neoplastic transformation were evaluated.
MATERIALS AND METHODS
Animals
Male C3H/HeOuJ mice, 10–12 weeks old, were purchased from
Jackson laboratories (Bar Harbor, Maine, NY, USA) and housed in
accordance with the guidelines of the Association for the
Assessment and Accreditation of Laboratory Animal Care.
The animals were maintained under normal conditions at ambient
temperature and relative humidity and fed with standard diet
provided by Jackson Laboratories. Tap water was provided
ad libitum. All experimental procedures were approved by the
University of Nebraska Medical Center Animal Care and Use
Committee Guidelines.
Escherichia coli strain and bacterial infection
Escherichia coli bacteria were grown from frozen stock by
two passages in tryptose broth (Difco Laboratories, Detroit, MI,
USA), washed with sterile phosphate-buffered saline (PBS) by
centrifugation, and resuspended to a concentration of 1 10
8
bacteriaml
 1. A group of six mice were deprived of water for 1h
and had urine expressed from their bladders immediately before
inoculation. The mice were anaesthetised with isoflurane and
inoculated intraurethrally, using a lubricated sterile polyethylene
catheter (Intramedic PE-10) (BD, Diagnostic System, Sparks, MD,
USA), with 20ml of bacterial inoculum resulting in a dose of
2 10
6 E. coli per mouse. Control mice were inoculated with an
equal volume of PBS. The animals were allowed to recover from
anaesthesia and were given free access to water 1h later. The mice
were killed at 5 days, or 12 or 26 weeks after inoculation. The
prostate of each animal was removed intact and bisected in the
mid-sagittal plane. One half was used for bacterial analysis as
described previously (Elkahwaji et al, 2005). The remaining half
was fixed in 10% formalin, and evaluated by light microscopy after
haematoxylin and eosin, immunohistochemistry, or immuno-
fluorescence staining.
Haematoxylin and eosin staining
All prostate tissues obtained from control and E. coli-infected
animals were processed routinely through graded concentrations
of alcohol and embedded in paraffin blocks. Five-micron sections
were cut, deparaffinised, and rehydrated in increasing concentra-
tions of ethanol. Tissues were rinsed with deionised water for 15s
and stained with haematoxylin for 4min. Samples were dehydrated
with 70% ethanol; followed by 95% ethanol for less than 5s. Eosin
was applied for 2min. After staining, samples were dehydrated in
an increasing series of ethanol (95% ethanol for 5s, 100% ethanol
for 5s, and then 100% ethanol for 5s) and cleared in xylene (twice
for less than 1min each and once for 2min).
In vivo 5-bromo-2-deoxy-uridine Labelling and
immunostaining
Male C3H/HeOuJ mice were treated by IP injection with 0.2ml of
5-bromo-2-deoxy-uridine (BrdU) (10mM) per mouse as instructed
(Roche Diagnostic GmbH, Mannheim, Germany). The mice were
killed 1h later and the prostates of both infected and control
groups were placed into a separate section of a multi-chamber
cassette for tissue processing, embedding, and sectioning. After
deparaffinisation and antigen retrieval, the prostatic cells were
immunostained using the BrdU Labeling and Detection Kit II
(Roche Diagnostic GmbH). Goat anti-mouse-Alexa 546-conjugated
antibody (Molecular Probes, Carlsbad, CA, USA) was used to
visualise the BrdU-stained prostatic cells. Sections were mounted
with Vectashield Hardset mounting mediaþDAPI counterstain
(Vector Laboratories Inc., Burlingame, CA, USA), and images were
taken using an Olympus model BX51 fluorescent microscope
equipped with DAPI and rhodamine filters and Spot Advanced
software v. 3.5.2 (Hitschfel Instruments, Inc., St Louis, MO, USA).
Immunofluorescence staining for oxidative DNA damage
Staining for oxidative DNA damage was carried out by an
immunofluorescence technique using a primary monoclonal
antibody against 8-hydroxy-deoxyguanosine (8-OH-dG) and by
applying the method of Yarborough et al (1996) with some
modifications. Briefly, after deparaffinisation and rehydratation,
prostate sections were treated sequentially with Ribonuclease A
(RNAse) (Sigma Chemical Co., St Louis, MO, USA) and Proteinase
K solution (Chemicon International, Temecula, CA, USA) for 1h
and 30min, respectively, at room temperature, followed by two
PBS washes for 1min each. After RNAse and Proteinase K
treatment, the sections were sequentially treated with HCl solution
for 7min and with 50mM Tris base solution to neutralise the
specimens and were then submerged in BioGenex Super Sensitive
Wash Buffer (Biogenex, San Ramon, CA, USA) at room
temperature. Prostate sections were incubated in Zymed Goat
Serum (10%) (Zymed Laboratories, Inc., San Francisco, CA, USA)
Inflammation induces neoplasia in mice
JE Elkahwaji et al
1741
British Journal of Cancer (2009) 101(10), 1740–1748 & 2009 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sfor 20min at room temperature to block nonspecific binding, then
incubated overnight at 41C with monoclonal anti-8-OH-dG mouse
antibody (1:100, QED) or with mouse immunoglobulin (Ig) G1
clone P3 isotype control (1:7500, eBioscience, San Diego, CA,
USA). After the overnight incubation, a secondary antibody was
applied (1:100, Goat anti-mouse IgG labelled with Alex Fluor 488
(Molecular Probes Inc., Eugene, OR, USA)) for 1h at room
temperature. Slides were washed twice with BioGenex Super
Sensitive Wash Buffer, tapped dry, mounted with Prolong Gold
Antifade Reagent (Molecular Probes Inc.), coverslipped, then
sealed with a clear lacquer sealant. Images were captured using a
fully automated Leica DMXRA2 microscope (North Central
Instruments, Plymouth, MN, USA).
Immunofluorescence staining in paraffin section
for p-class glutathione-S-transferase, cyclin-dependent
kinase inhibitor (p27
Kip1), and tumour suppressor gene
phosphatase and tensin homologue
Five-micron prostate sections were cut, deparaffinised in xylene,
and rehydrated in a graded concentration of alcohol and distilled
water. Antigen retrieval was performed in citrate buffer (pH¼6)
using an electric pressure cooker (Biocare Medical, Walnut Creek,
CA, USA) at 1201C for 2min (Norton et al, 1994), followed by
rehydration in PBS and incubation in Zymed Goat Serum (10%)
for 20min at room temperature to block nonspecific binding.
Different prostate sections were incubated overnight at 41C
with monoclonal anti-p27
Kip1 mouse antibody (1:20, Vector
Laboratories Inc.), polyclonal anti-GSTP1 rabbit antibody
(1:100, Vector Laboratories Inc.), or polyclonal anti-PTEN rabbit
antibody (1:200, Abcam Inc. Cambridge, MA, USA). Control
prostate sections were incubated with rabbit or mouse isotype
control (Invitrogen Corporation, Camarillo, CA, USA). After the
overnight incubation, a secondary antibody was applied (1:200,
Goat anti-mouse IgG labelled with Alex Fluor 488 or Goat anti-
rabbit IgG labelled with Alex Fluor 568 (Molecular Probes Inc.))
for 1h at room temperature. Slides were washed twice with
BioGenex Super Sensitive Wash Buffer, tapped dry, mounted
with Prolong Gold Antifade Reagent (Molecular Probes Inc.),
coverslipped, then sealed with a clear lacquer sealant. Images were
captured using a fully automated Leica DMXRA2 microscope
(North Central Instruments).
Immunohistochemistry in paraffin section for androgen
receptor
Five-micron sections were cut, deparaffinised in xylene, and
rehydrated in a graded concentration of alcohol and distilled
water. Antigen retrieval was performed in citrate buffer (pH¼6)
using an electric pressure cooker (Biocare Medical) at 1201C for
2min (Norton et al, 1994), and endogenous peroxidase activity was
blocked with 3% hydrogen peroxide in methanol for 30min,
followed by rehydration in PBS and incubation with 5% normal
goat serum for 30min at room temperature to bind nonspecific
antigens. Prostate tissue sections were then incubated for 1h with
rabbit polyclonal antibody against androgen receptor (AR, 1/20;
Novocastra, Burlingame, CA, USA). After washing unbound primary
antibody, sections were treated for 45min at room temperature with
specific commercial biotinylated secondary anti-IgG, followed by
avidin coupled to biotinylated horseradish peroxidase, according to
the manufacturer’s instructions (the LSAB2 kit for rabbit primary
antibodies, DAKO Corporation, Carpinteria, CA, USA). Diamino-
benzidine was applied as the chromogenic peroxidase substrate for
3–5min at room temperature to reveal staining. Sections were
counterstained with haematoxylin for 1–2min and analysed by
standard light microscopy. Specificity was verified by negative
control reactions in which the primary antibody was replaced with
normal rabbit serum.
RESULTS
In this study, we assessed the prostate infection intensities at
5 days, and at 12 and 26 weeks after infection (Table 1) in C3H/
HeOuJ male mice after inoculation with PBS (n¼18) or with
2 10
6 uropathogenic E. coli bacteria (n¼36). The quantitative
colony-forming unit (CFU) per mg of prostate tissue showed no
significant prostate infections in PBS control mice at either time
points. In contrast, all infected C3H/HeOuJ mice with 2 10
6
bacteria developed acute bacterial prostatitis at 5 days, and active
chronic bacterial prostatitis at both 12 and 26 weeks. The intensity
of prostate infection was more pronounced at 26 weeks when
compared with the infection intensity found at 5 days and 12 weeks
(138, 9375, and 30785 CFU per mg of prostate tissue, at 5 days, and
at 12 and 26 weeks, respectively).
In addition, our bacteriological studies were supplemented by
histological examination of prostate tissues collected at 5 days,
and at 12 and 26 weeks after instillation of PBS or 2 10
6
uropathogenic E. coli bacteria. Control mice inoculated with PBS
revealed a normal prostate architecture, normal epithelial mor-
phology, and absence of inflammatory cell infiltrate (Figure 1A). In
contrast, prostate tissues obtained from C3H/HeOuJ mice inocu-
lated with uropathogenic bacteria for 5 days exhibited multiple foci
of acute inflammation associated with acute inflammatory cells
(neutrophils), epithelial necrotic debris, and an abundant shedding
of epithelial cells in the prostatic glandular lumen (Figure 1B). At
12 weeks after infection, acute inflammation decreased and focal
residual acute inflammation was present in prostatic glands.
In addition, focal mild-to-moderate chronic inflammation was
present in the stroma. Most significantly, the prostatic glandular
epithelium showed varying degrees of atypical hyperplasia with
increased epithelial layers, severe cytological atypia, and dysplastic
changes of glandular architecture (Figure 1C). The prostatic glands
were distorted and became irregular with a bulging profile
associated with prominent chronic inflammation, whereas acute
inflammation subsided. Sites of intense inflammation were
associated with moderate or dense lymphocytic infiltrate in the
Table 1 Prostate infection intensities in C3H/HeOuJ mice inoculated with PBS or E. coli bacteria after 5 days, 12 and 26 weeks
C3H/HeOuJ mice
a
5 days 12 weeks 26 weeks
n
b CFU
c P-value
d n CFU P-value n CFU P-value
PBS 6 0 — 6 0 — 6 0 —
2 10
6 E. coli bacteria 6 138 0.001 6 9375 0.001 6 30785 0.001
Abbreviations: CFU¼colony-forming unit; E. coli¼Escherichia coli; PBS¼phosphate-buffered saline.
aMice infected with PBS or with E. coli bacteria on day 0.
bNumber of mice
infected in each experimental group.
cGeometric mean of CFU per mg of tissue for each experimental group at 5 days, and at 12 and 26 weeks after inoculation.
dP-values for
comparisons of prostate CFU values between groups of E. coli infected and PBS mice were determined by Fisher’s protected least significant difference test.
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speriglandular stroma and shedding of epithelial cells into the
glandular lumen (Figure 1D). The dysplastic changes observed at
this stage mimic a high-grade PIN, a potential precursor to CaP in
human prostate (Figure 2A and B). Furthermore, prostate tissues
obtained from additional mice and examined histologically 26
weeks after inoculation showed intense chronic inflammatory
changes similar to those evident at 12 weeks after inoculation, but
the dysplastic changes were more pronounced at this stage, nearly
Figure 1 Acute and chronic prostatic inflammation induced by E. coli bacterial infection in C3H/HeOuJ mice. (A) PBS-control prostate. (B) Acute
prostatic inflammation 5 days after infection characterised by acute inflammatory cells. (C) Mild-to-moderate chronic inflammation at 12 weeks after
infection associated with variant degrees of atypical hyperplasia and dysplasia. (D) Severe chronic inflammation at 26 weeks associated with severe dysplasia
and cytological atypia (magnification  40).
HGPIN
PIN
Figure 2 Chronic bacterial inflammation induces dysplastic changes in mouse prostate. (A and B) Chronic inflammation induces high-grade prostatic
intraepithelial neoplasia at 12 weeks after inoculation. (C and D) Dysplastic changes associated with severe chronic inflammation observed at 26 weeks after
infection and mimicking a high-grade dysplasia and an invasive carcinoma (magnification  40).
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sreplacing the normal glandular architecture and mimicking a high-
grade dysplasia or a cancer-like lesion (carcinoma in situ/invasive
carcinoma) (Figure 2C and D). These data suggest that chronic
bacterial infection induced a PIN lesion associated with severe
chronic inflammation and this prostate lesion is similar to the PIN
lesion described by De Marzo and colleagues that occurs in close
proximity to foci of chronic inflammation and that constitute a
potential precursor to human prostate adenocarcinoma.
To determine whether the PIN lesion and severe dysplatic
changes associated with chronic inflammation were because of an
increase in prostatic epithelial cell proliferation, mice were treated
with BrdU 1h before being killed, then a quantitative analysis of
BrdU incorporated into the newly synthesised DNA of replicating
prostatic epithelial cells was performed (Figure 3). We observed a
very low labelling index in PBS prostate tissue. Staining for BrdU
showed a clear increase in prostatic epithelial cell proliferation in
glands exhibiting PIN lesion and severe dysplasia observed at 12
and 26 weeks after infection. Moreover, the prostate tissues
exhibiting PIN lesions and high severe dysplasia showed a clear
decrease in p27
Kip1 expression, a suppressor of prostatic epithelial
cell proliferation, when compared with PBS-control prostate
(Figure 4). These results support the conclusion that PIN lesion
and the dysplastic changes associated with chronic bacterial
infection and inflammation occurred in conjunction with in-
creased prostatic epithelial cell proliferation.
The association between CaP risk and oxidative stress has been
recognised, and epidemiological, experimental, and clinical studies
have unequivocally proven a role of oxidative stress (reactive
oxygen and nitrogen species) in the development and progression
of the disease. These reactive oxygen species (ROS), in the absence
of GSTP1, which function as an inducible phase II detoxifying
enzyme for ROS and organic electrophiles, induce tissue injury
and DNA damage, which are general manifestations of patholo-
gical conditions associated with infection, inflammation, and
epithelial cell proliferation. In this study, we performed an
immunofluorescence staining for the oxidative stress-associated
marker 8-OH-dG (Figure 5) and for the caretaker gene GSTP1 to
ensure that PIN lesion and the dysplastic changes associated with
chronic bacterial inflammation occurred in a microenvironment
rich in ROS. Nuclear staining for 8-OH-dG was rare in PBS control
prostate. However, prostate tissues exhibiting PIN lesion and
severe dysplasia demonstrated an increased nuclear staining for
Figure 3 Prostatic epithelial cell proliferation induced by chronic inflammation. (A) PBS-control tissues show sparse staining for BrdU. (B and C) Prostate
tissues exhibiting a varying degree of atypical hyperplasia and dysplasia at 12 weeks after inoculation show numerous BrdU-stained epithelial nuclei.
(D) Prostate tissue exhibiting high-grade dysplasia or cancer-like lesion at 26 weeks after infection show an increased number of BrdU-stained epithelial
nuclei as compared with PBS-control and 12 week-infected prostate tissues (magnification  40).
A BC
Figure 4 Expression of the cyclin-dependent kinase inhibitor (p27
Kip1) in mouse prostate. (A) PBS-control prostate showing a positive staining for
p27
Kip1, a suppressor of prostatic epithelial cell proliferation. (B and C) Prostate tissues exhibiting severe dysplastic changes and mimicking a high-grade PIN
and carcinoma in situ, showing a negative staining for p27
Kip1 when compared with PBS-control prostate (magnification  20).
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soxidative DNA damage (Figure 5) and an absence of GSTP1
expression (Figure 6) when compared with the PBS-control
prostate. These data suggest that PIN lesion and severe dysplasia
mimicking a cancer-like lesion arise as a consequence of the
regenerative proliferation of prostate epithelial cells in response to
injury caused by inflammatory oxidants in response to bacterial
infection.
The progression from PIN lesion to localised then advanced CaP
occurred in an androgen-independent manner. This phenomenon
reflects the ability of prostatic epithelial cells to sustain growth and
proliferation even in the absence of androgen, thus acquiring
androgen independency and an aggressive phenotype. Similarly,
this progression occurs during some genomic alterations resulting
in loss or inactivation of many tumour suppressor genes such as
PTEN, a phosphatase and tensin homologue involved in several
signalling pathways that regulate cell growth and survival. In this
study, we performed an immunostaining for AR and PTEN
expression to determine whether the dysplastic changes mimicking
a cancer-like lesion acquire an androgen independency (Figure 7)
and to ensure that lost or inactivated tumour suppressor gene
PTEN will promote the progression of prostate carcinogenesis
(Figure 8). A decrease in AR and a loss of PTEN expressions were
observed in the atypical prostate gland as compared with normal
and simple hyperplastic glands, suggesting that the papillary
form of the neoplastic lesion induced by chronic bacterial
inflammation may progress towards an invasive cancer by
bypassing androgens and the AR, and indeed occurs during PTEN
loss or inactivation.
DISCUSSION
Prostate cancer remains a major concern of public health in the
United States. Tremendous morbidity, mortality, and economic
costs are associated with screening, treatment, and palliation of the
disease. Aetiological factors that initiate and enhance the progres-
sion of this malignancy are beginning to emerge, with strong
evidence that chronic inflammation and uncontrolled cell pro-
liferation within the prostate are linked to initiation and neoplastic
conversion. This evidence suggests that dietary strategies targeting
inflammation and proliferation would be effective in limiting CaP
development.
Histopathological studies of human prostate reveal a prevalence
of inflammatory changes in the peripheral zone of the prostate, the
most common site of tumourigenesis (McNeal, 1988). In addition,
molecular epidemiological studies indicate a high prevalence of
colonisation of the prostate, with inconclusively identified
bacterial species in men with chronic prostatitis (Hochreiter
et al, 2002). Because E. coli is the most common pathogen
identified in acute prostatitis in humans (Mitsumori et al, 1999)
and is able to induce acute and chronic bacterial prostatitis in rats
(Nickel et al, 1990; Rippere-Lampe et al, 2001), we developed a new
mouse model of bacterial prostatitis to study the relationships
between bacterial infection and inflammation, oxidative stress, and
prostatic carcinogenesis. In this study, all C3H/HeOuJ inbred male
mice, known to be highly susceptible to infection, developed acute
bacterial prostatitis at 5 days and severe, chronic bacterial
prostatitis at 12 and 26 weeks after inoculation with E. coli
bacteria. In addition, E. coli infection induced a focal acute
inflammation within the prostate at day 5 and chronic prostatic
inflammation at 12 and 26 weeks after infection. Most significantly,
the prostatic glandular epithelium showed atypical hyperplasia
associated with increased epithelial cell layers, cytological atypia,
and dysplastic changes of glandular architecture. In contrast, PBS
control mice had no prostate infection and inflammation at any
time point. These results are consistent with those observed in rats
(Reznik et al, 1981; Wilson et al, 1990), in which prostatic
inflammation, accompanied by focal epithelial atrophy, may also
Figure 5 Chronic bacterial inflammation induces oxidative DNA damage in mouse prostate. (A) Prostate tissues after PBS treatment showing a low
nuclear staining for 8-hydroxy-20-deoxyguanosine (8-OH-dG), a marker for oxidative DNA damage. (B) Prostate tissues exhibiting a varying degree of
atypical hyperplasia and severe dysplasia after bacterial infection showing an increased staining for 8-OH-dG in prostatic epithelial nuclei (magnification
 40).
Figure 6 Expression of the p-class glutathione-S-transferase (GSTP1) in mouse prostate. (A) PBS-control prostate showing a high level of GSTP1, the
function of which induces phase II detoxifying enzymes for reactive oxygen species and organic electrophiles. (B and C) Prostate tissues exhibiting a high-
grade PIN and carcinoma in situ showing an absence of GSTP1 expression when compared with PBS-control prostate (magnification  20).
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scontribute to the development of CaP and reinforced the potential
linkage between prostatic inflammation and aetiology of CaP.
Recently, De Marzo et al (1999b) proposed a hypothesis of CaP
development on the basis of chronic inflammation, ROS-induced
genomic damage, and neoplastic transformation. The central
concept of this hypothesis is that carcinogenesis results from
repeated tissue damage and regeneration in the presence of ROS
and reactive nitrogen species (RNS) released from inflammatory
cells. In both acute and chronic infections, infiltrating leukocytes
and phagocytic cells destroy bacteria, parasites, and virus-infected
cells by producing ROS and RNS (Ames et al, 1995). The presence
of ROS and RNS causes oxidative damage to cellular DNA,
proteins, and lipids, leading to genetic mutations, chronic cell
killing, and compensatory cell division. It is conceivable that
repeated host inflammatory responses due to long-term bacterial
colonisation could provide one source of ROS-producing neu-
trophils. Reactive molecules would be expected to interact with
genomic or mitochondrial DNA in normal prostate epithelial
cells, causing genomic alterations such as point mutations,
deletions, or rearrangements that accumulate and become
permanent in the genome of proliferating cells (Oberley, 2002).
This sequence may thus provide a mechanism for prostate
carcinogenesis (Penta et al, 2001).
In this study, prostate tissue sections, analysed by light
microscopy, showed infiltration of neutrophils associated with
acute prostatic inflammation at 5 days after bacterial inoculation
and an infiltration of lymphocytes and/or macrophages associated
with chronic prostatic inflammation at 12 and 26 weeks after
infection. Furthermore, prostate tissue sections showed an increase
in the nuclear staining index of oxidative stress-associated marker,
8-OH-dG, and a decrease in GSTP1 expression at 12 and 26 weeks
after infection when compared with PBS-control prostate. These
results support the hypothesis of De Marzo and his colleagues, and
suggest that loss of GSTP1 gene expression, probably as a result of
hypermethylation of the CpG island sequences of GSTP1, will
render the prostatic epithelial cells more vulnerable to genomic
damage mediated by the infection itself or by the oxidant
carcinogens elaborated by inflammatory cells (neutrophils, lym-
phocytes, and macrophages) (Nelson et al, 2003). Moreover, as
suggested by De Marzo et al (1999b), the genomic DNA damage
generated during chronic inflammation induced by bacterial insult
may enhance the likelihood of neoplastic transformation.
In this inflammation-oxidative stress model, the progression of
prostate epithelial cells from normal to neoplastic is marked by
defined histological changes (De Marzo et al, 1999b; Nelson et al,
2002). The earliest lesion observed is PIA (De Marzo et al, 1999a,b;
Nelson et al, 2001), characterised by discrete foci of proliferative
glandular epithelium with the morphological appearance of focal
simple atrophy (Ruska et al, 1998) or postatrophic hyperplasia
(Cheville and Bostwick, 1995), occurring in close association with
chronic inflammation. An important feature of PIA is that the
majority of lesions are associated with long-standing inflammation
in the prostate, and many of the proliferating cells have an
immature basal secretory cell phenotype similar to those found in
PIN and CaP. Thus, this model strongly suggests that PIA
associated with chronic inflammation may give rise to prostate
carcinoma directly or indirectly by progression into high-grade
PIN lesions (De Marzo et al, 1999a,b, 2003; Nelson et al, 2001).
In our study, chronic prostatic inflammation induced by E. coli
bacteria was prominent at 12 weeks after infection, whereas acute
inflammation subsided. Moreover, the chronic inflammation was
more pronounced at 26 weeks after inoculation and was associated
Figure 8 Expression of the tumour suppressor gene phosphatase and tensin homologue (PTEN) in mouse prostate. (A) PBS-control prostate showing a
high level of PTEN expression. (B) Prostate tissue exhibiting severe dysplastic changes and mimicking high-grade PIN and carcinoma in situ showing a loss of
expression of PTEN when compared with PBS-control prostate (magnification  40).
Figure 7 Immunstaining for the androgen receptor (AR) in mouse prostate. (A) PBS-contol prostate showing a positive staining for androgen receptor
(arrows). (B) Prostate tissues exhibiting severe dysplasia after bacterial infection showing a decreased staining for androgen receptor as compared with PBS-
control prostate (arrowhead) (magnification  40).
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swith severe dysplasia, characterised by complex glandular
architecture and severe cytological atypia mimicking PIN or
cancer-like lesions. Immunohistochemical analysis showed that
the infected prostate had increased BrdU nuclear staining and a
decrease in p27
Kip1 expression compared with PBS-control
prostate. These results support Virchow’s hypothesis that chronic
inflammation of long-standing duration can lead to cellular
proliferation and cancer development (Balkwill and Mantovani,
2001). Moreover, the results suggest that proliferation of prostatic
epithelial cells in the milieu of oxy-radical barrage may result in
conversion of DNA damage to persistent mutations, some of which
may provide prostatic cells with growth and/or antiapoptotic
advantage. Therefore, chronic inflammation may be an initiator
and a promoter of prostatic carcinogenesis through genotoxic and
cytotoxic effects (Platz and De Marzo, 2004).
Overall, these results suggest that chronic prostatic inflamma-
tion may be a major factor in predisposition to prostatic
carcinogenesis. During the malignant transformation of the
prostate, AR may dissociate from heat-shock proteins and
translocate into the nucleus, dimerise, bind to androgen-response
elements in DNA, and activate several transcription genes involved
in cell growth and survival (Debes and Tindall, 2004). It is well
known that androgenic hormones and AR both have critical roles
in normal prostate development function and in most prostate
diseases, including CaP. Several clinical studies have shown
that withdrawal of androgens leads to a rapid decline in CaP
growth with significant clinical response. This response is short
lived and tumour cells may re-emerge independently of androgen
stimulation by acting through several mechanisms, including
amplification of the AR gene or bypassing the AR by deregulating
apoptotic genes. Amplification of the AR gene, accompanied by
overexpression of the receptor, could lead to androgen-indepen-
dent CaP-cell growth by increasing the sensitivity of CaP cells to
low concentrations of circulating androgens (Debes and Tindall,
2004). Furthermore, by bypassing AR, both PTEN and the
antiapoptotic gene bcl-2 have important roles in androgen-
refractory CaP. Loss of PTEN activity reverses the inhibition of
the phosphatidylinositol-3-kinase (PI3-K)-Akt pathway, permit-
ting Bad phosphorylation by activated Akt. This PI3-K-Akt
activation results in the release of Bcl-2, leading to cell growth
and survival (Debes and Tindall, 2004). These two mechanisms are
consistent with our observation of decreased expression of AR,
loss of PTEN, and increased expression of BrdU incorporated
into the newly synthesised DNA of replicating prostatic epithelial
cells observed in the atypical prostatic gland mimicking PIN or
cancer-like lesions as compared with normal and simple
hyperplastic glands. Further molecular studies are needed to
determine the mechanisms by which high-grade PIN induced
by chronic bacterial infection and inflammation progresses
towards an invasive carcinoma independently of circulating
androgens and AR.
In the last decade, an increasing number of epidemiological and
experimental studies have seemed to re-ignite the concept that
long-standing chronic inflammation potentiates or promotes
tumour development, growth, and progression. Long-standing
chronic inflammation seems to have an active role in carcinogen-
esis and is now recognised as an important risk factor in the
development of a number of malignancies with an infectious
aetiology, such as stomach (Helicobacter pylori), liver (hepatitis B
and C viruses), and colon cancer in patients with inflammatory
bowel diseases (Ames et al, 1995; Giovannucci, 2001). It is also
hypothesised that chronic inflammation may lead to the develop-
ment and progression of prostatic carcinoma, although a direct
causal role for chronic inflammation or infection in prostatic
carcinogenesis is yet to be confirmed in humans.
Our study demonstrates that prostatic infection and inflamma-
tion results in focal prostatic glandular atypia (e.g., PIN and severe
dysplasia), a potential precursor of prostatic adenocarcinoma. In
addition, our results suggest a potential relationship between
chronic inflammation and oxidative DNA damage that may have a
role in prostate carcinogenesis. Further studies are needed to
define the morphological and immunophenotypical changes with-
in the prostate induced by chronic infection and to clarify a
potential linkage between E. coli infection and inflammation in the
aetiology of CaP. Moreover, E. coli-induced prostatitis will provide
a valuable model system to determine the influence of host genetic
factors on the development of CaP in an inflammatory milieu and
to design new strategies for CaP prevention.
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